BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002;52:19-24. [PMID: 11940202 DOI: 10.1046/j.1440-1827.2002.01316.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hirama M, Takahashi F, Takahashi K, Akutagawa S, Shimizu K, Soma S, Shimanuki Y, Nishio K, Fukuchi Y. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Letters 2003;198:107-17. [DOI: 10.1016/s0304-3835(03)00286-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
3 Bhattacharya SD, Mi Z, Talbot LJ, Guo H, Kuo PC. Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers. Surgery 2012;152:449-54. [PMID: 22938903 DOI: 10.1016/j.surg.2012.06.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
4 Zhang X, Ye LH, Zhang XD. A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase. Acta Pharmacol Sin 2010;31:593-600. [PMID: 20364155 DOI: 10.1038/aps.2010.36] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
5 Sahai A, Malladi P, Melin-aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. American Journal of Physiology-Gastrointestinal and Liver Physiology 2004;287:G264-73. [DOI: 10.1152/ajpgi.00002.2004] [Cited by in Crossref: 137] [Cited by in F6Publishing: 133] [Article Influence: 7.6] [Reference Citation Analysis]
6 Shin HD, Park BL, Cheong HS, Yoon JH, Kim YJ, Lee HS. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int J Epidemiol. 2007;36:1001-1008. [PMID: 17496055 DOI: 10.1093/ije/dym093] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bruha R, Vitek L, Smid V. Osteopontin - A potential biomarker of advanced liver disease. Ann Hepatol 2020;19:344-52. [PMID: 32005637 DOI: 10.1016/j.aohep.2020.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
8 Gong M, Lu Z, Fang G, Bi J, Xue X. A small interfering RNA targeting osteopontin as gastric cancer therapeutics. Cancer Lett. 2008;272:148-159. [PMID: 18694621 DOI: 10.1016/j.canlet.2008.07.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lovisa F, Garbin A, Crotti S, Di Battista P, Gallingani I, Damanti CC, Tosato A, Carraro E, Pillon M, Mafakheri E, Romanato F, Gaffo E, Biffi A, Bortoluzzi S, Agostini M, Mussolin L. Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers? Diagnostics (Basel) 2021;11:253. [PMID: 33562105 DOI: 10.3390/diagnostics11020253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ito K, Kon S, Nakayama Y, Kurotaki D, Saito Y, Kanayama M, Kimura C, Diao H, Morimoto J, Matsui Y, Uede T. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration. Matrix Biol 2009;28:11-9. [PMID: 19000758 DOI: 10.1016/j.matbio.2008.10.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
11 Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C, Mantovani A, Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol 2010;185:642-52. [PMID: 20530259 DOI: 10.4049/jimmunol.1000413] [Cited by in Crossref: 251] [Cited by in F6Publishing: 240] [Article Influence: 20.9] [Reference Citation Analysis]
12 Tajiri T, Tate G, Kunimura T, Endo Y, Inoue K, Mitsuya T, Morohoshi T, Yoshiba M. Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis. Dig Dis Sci 2005;50:188-95. [PMID: 15712659 DOI: 10.1007/s10620-005-1299-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
13 Matsue Y, Tsutsumi M, Hayashi N, Saito T, Tsuchishima M, Toshikuni N. Serum Osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection. PLoS One. 2015;10:e0118744. [PMID: 25760884 DOI: 10.1371/journal.pone.0118744] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
14 Čunderlíková B. Clinical significance of immunohistochemically detected extracellular matrix proteins and their spatial distribution in primary cancer. Critical Reviews in Oncology/Hematology 2016;105:127-44. [DOI: 10.1016/j.critrevonc.2016.04.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Bour G, Martel F, Goffin L, Bayle B, Gangloff J, Aprahamian M, Marescaux J, Egly JM. Design and development of a robotized system coupled to µCT imaging for intratumoral drug evaluation in a HCC mouse model. PLoS One 2014;9:e106675. [PMID: 25203629 DOI: 10.1371/journal.pone.0106675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
16 Zhang A, Liu Y, Shen Y, Xu Y, Li X. Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells. Med Oncol 2010;27:1179-84. [PMID: 19921477 DOI: 10.1007/s12032-009-9356-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
17 Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci. 2008;103:4-13. [PMID: 17890765 DOI: 10.1093/toxsci/kfm246] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 7.9] [Reference Citation Analysis]
18 Jang T, Sathy B, Hsu Y, Merchant M, Recht B, Chang C, Recht L. A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection: Laboratory investigation. JNS 2008;108:782-90. [DOI: 10.3171/jns/2008/108/4/0782] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
19 Wu JC, Sun BS, Ren N, Ye QH, Qin LX. Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. J Cancer Res Clin Oncol. 2010;136:595-601. [PMID: 19834740 DOI: 10.1007/s00432-009-0695-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
20 Iqbal J, McRae S, Mai T, Banaudha K, Sarkar-Dutta M, Waris G. Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes. PLoS One 2014;9:e87464. [PMID: 24498111 DOI: 10.1371/journal.pone.0087464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
21 Malaponte G, Hafsi S, Polesel J, Castellano G, Spessotto P, Guarneri C, Canevari S, Signorelli SS, McCubrey JA, Libra M. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression. Biochim Biophys Acta 2016;1863:483-9. [PMID: 26381542 DOI: 10.1016/j.bbamcr.2015.09.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
22 Zhang GX, Zhao ZQ, Wang HD, Hao B. Enhancement of osteopontin expression in HepG2 cells by epidermal growth factor via phosphatidylinositol 3-kinase signaling pathway. World J Gastroenterol 2004; 10(2): 205-208 [PMID: 14716823 DOI: 10.3748/wjg.v10.i2.205] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
23 Chuang CY, Chang H, Lin P, Sun SJ, Chen PH, Lin YY, Sheu GT, Ko JL, Hsu SL, Chang JT. Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer. Gene 2012;492:262-9. [PMID: 22037483 DOI: 10.1016/j.gene.2011.10.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
24 Moseley RH. Progress in understanding the pathogenesis of nonalcoholic fatty liver disease. Hepatology 2005;41:204-6. [PMID: 15619243 DOI: 10.1002/hep.20558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Rychlíková J, Vecka M, Jáchymová M, Macášek J, Hrabák P, Zeman M, Vávrová L, Řoupal J, Krechler T, Ák A. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Cancer Biomark 2016;17:55-65. [PMID: 27314293 DOI: 10.3233/CBM-160617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Arai M, Yokosuka O, Kanda T, Fukai K, Imazeki F, Muramatsu M, Seki N, Miyazaki M, Ochiai T, Hirasawa H. Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol. 2006;41:102-110. [PMID: 16373283 DOI: 10.1080/00365520510024061] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
27 Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract. 2008;62:1056-1062. [PMID: 17537188 DOI: 10.1111/j.1742-1241.2007.01368.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
28 Zhang H, Ye QH, Ren N, Zhao L, Wang YF, Wu X, Sun HC, Wang L, Zhang BH, Liu YK. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2006;132:709-717. [PMID: 16786357 DOI: 10.1007/s00432-006-0119-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
29 Hoseini SS, Cheung NV. Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies. Cancer Lett. 2017;399:44-52. [PMID: 28428075 DOI: 10.1016/j.canlet.2017.04.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
30 Wu GL, Zhang L, Li TY, Chen J, Yu GY, Li JP. Short-term effect of combined therapy with Jinlong Capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression. Chin J Integr Med. 2010;16:109-113. [PMID: 20473734 DOI: 10.1007/s11655-010-0109-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
31 Chan KY, Wong N, Lai PB, Squire JA, Macgregor PF, Beheshti B, Albert M, To KF, Johnson PJ. Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma. Int J Cancer. 2005;114:902-908. [PMID: 15645427 DOI: 10.1002/ijc.20684] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
32 Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med. 2010;14:2037-2044. [PMID: 20597997 DOI: 10.1111/j.1582-4934.2010.01115.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 9.7] [Reference Citation Analysis]
33 Lee HJ, Yeon JE, Suh SJ, Lee SJ, Yoon EL, Kang K, Yoo YJ, Kim JH, Seo YS, Yim HJ. Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma. Gut Liver. 2014;8:177-185. [PMID: 24672660 DOI: 10.5009/gnl.2014.8.2.177] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
34 Girard S, Vossman E, Misek DE, Podevin P, Hanash S, Bréchot C, Beretta L. Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology 2004;40:708-18. [PMID: 15349911 DOI: 10.1002/hep.20371] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
35 Sieghart W, Wang X, Schmid K, Pinter M, König F, Bodingbauer M, Wrba F, Rasoul-Rockenschaub S, Peck-Radosavljevic M. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria. J Hepatol. 2011;54:89-97. [PMID: 20970216 DOI: 10.1016/j.jhep.2010.06.030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
36 Ito K, Nakajima A, Fukushima Y, Suzuki K, Sakamoto K, Hamazaki Y, Ogasawara K, Minato N, Hattori M. The potential role of Osteopontin in the maintenance of commensal bacteria homeostasis in the intestine. PLoS One 2017;12:e0173629. [PMID: 28296922 DOI: 10.1371/journal.pone.0173629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
37 Takami Y, Russell MB, Gao C, Mi Z, Guo H, Mantyh CR, Kuo PC. Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells. Surgery. 2007;142:163-169. [PMID: 17689681 DOI: 10.1016/j.surg.2007.02.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
38 Wang X, Chao L, Zhen J, Chen L, Ma G, Li X. Phosphorylated c-Jun NH2-terminal kinase is overexpressed in human papillary thyroid carcinomas and associates with lymph node metastasis. Cancer Letters 2010;293:175-80. [DOI: 10.1016/j.canlet.2010.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS. Hepatocellualar carcinoma serum markers. Semin Oncol. 2012;39:410-433. [PMID: 22846859 DOI: 10.1053/j.seminoncol.2012.05.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 10.3] [Reference Citation Analysis]
40 Zhang X, You X, Wang Q, Zhang T, Du Y, Lv N, Zhang Z, Zhang S, Shan C, Ye L. Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration. PLoS One. 2012;7:e31458. [PMID: 22355367 DOI: 10.1371/journal.pone.0031458] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
41 El-din Bessa SS, Elwan NM, Suliman GAM, El-shourbagy SH. Clinical Significance of Plasma Osteopontin Level in Egyptian Patients with Hepatitis C Virus-related Hepatocellular Carcinoma. Archives of Medical Research 2010;41:541-7. [DOI: 10.1016/j.arcmed.2010.10.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
42 Wai PY, Reddy SK, Kuo PC. Functional analysis of tumor metastasis: modeling colon cancer. Oncol Rev 2008;2:9-20. [DOI: 10.1007/s12156-008-0051-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006;44:1012-1024. [PMID: 17006932 DOI: 10.1002/hep.21328] [Cited by in Crossref: 200] [Cited by in F6Publishing: 216] [Article Influence: 12.5] [Reference Citation Analysis]
44 Chen RX, Xia YH, Cui JF, Xue TC, Ye SL. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. J Gastroenterol Hepatol. 2010;25:1435-1442. [PMID: 20659235 DOI: 10.1111/j.1440-1746.2010.06277.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
45 Potikha T, Pappo O, Mizrahi L, Olam D, Maller SM, Rabinovich GA, Galun E, Goldenberg DS. Lack of galectin‐1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model. FASEB j 2019;33:7995-8007. [DOI: 10.1096/fj.201900017r] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
46 Nabih MI, Aref WM, Fathy MM. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma. Arab J Gastroenterol. 2014;15:103-107. [PMID: 25249230 DOI: 10.1016/j.ajg.2014.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
47 Khalil A, Elgedawy J, Faramawi MF, Elfert A, Salama I, Abbass A, Elsaid H, Elsebaai H. Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions. Tumori 2013;99:100-7. [DOI: 10.1177/030089161309900117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
48 Nuñez-Garcia M, Gomez-Santos B, Buqué X, García-Rodriguez JL, Romero MR, Marin JJG, Arteta B, García-Monzón C, Castaño L, Syn WK, Fresnedo O, Aspichueta P. Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver. J Lipid Res 2017;58:1903-15. [PMID: 28754826 DOI: 10.1194/jlr.M078980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Jin M, Dewa Y, Kawai M, Nishimura J, Saegusa Y, Kemmochi S, Harada T, Shibutani M, Mitsumori K. Induction of liver preneoplastic foci in F344 rats subjected to 28-day oral administration of diheptyl phthalate and its in vivo genotoxic potential. Toxicology 2009;264:16-25. [DOI: 10.1016/j.tox.2009.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
50 Zhang J, Guo H, Mi Z, Gao C, Bhattacharya S, Li J, Kuo PC. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. Exp Cell Res. 2009;315:304-312. [PMID: 19026636 DOI: 10.1016/j.yexcr.2008.10.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
51 Mi Z, Guo H, Russell MB, Liu Y, Sullenger BA, Kuo PC. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. Mol Ther. 2009;17:153-161. [PMID: 18985031 DOI: 10.1038/mt.2008.235] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 7.0] [Reference Citation Analysis]
52 Takemura F, Inaba N, Miyoshi E, Furuya T, Terasaki H, Ando S, Kinoshita N, Ogawa Y, Taniguchi N, Ito S. Optimization of liver biopsy RNA sampling and use of reference RNA for cDNA microarray analysis. Anal Biochem 2005;337:224-34. [PMID: 15691502 DOI: 10.1016/j.ab.2004.10.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
53 Mi Z, Guo H, Wai PY, Gao C, Kuo PC. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Carcinogenesis 2006;27:1134-45. [PMID: 16474180 DOI: 10.1093/carcin/bgi352] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
54 Lin F, Li Y, Cao J, Fan S, Wen J, Zhu G, Du H, Liang Y. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells. Mol Biol Rep. 2011;38:5205-5210. [PMID: 21188534 DOI: 10.1007/s11033-010-0671-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
55 Volante M, Rapa I, Metovic J, Napoli F, Tampieri C, Duregon E, Terzolo M, Papotti M. Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications. J Pers Med 2021;11:378. [PMID: 34066306 DOI: 10.3390/jpm11050378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Cao DX, Li ZJ, Jiang XO, Lum YL, Khin E, Lee NP, Wu GH, Luk JM. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol 2012; 18(30): 3923-3930 [PMID: 22912540 DOI: 10.3748/wjg.v18.i30.3923] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
57 Zhou Y, Dai DL, Martinka M, Su M, Zhang Y, Campos EI, Dorocicz I, Tang L, Huntsman D, Nelson C, Ho V, Li G. Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 2005;124:1044-52. [PMID: 15854047 DOI: 10.1111/j.0022-202X.2005.23680.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
58 Lau DT, Luxon BA, Xiao SY, Beard MR, Lemon SM. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology 2005;42:273-81. [PMID: 15986378 DOI: 10.1002/hep.20767] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
59 Beausoleil MS, Schulze EB, Goodale D, Postenka CO, Allan AL. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis. BMC Cancer 2011;11:25. [PMID: 21247495 DOI: 10.1186/1471-2407-11-25] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
60 Kaps L, Schuppan D. Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells 2020;9:E2027. [PMID: 32899119 DOI: 10.3390/cells9092027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
61 Zhang LH, Ji JF. Molecular profiling of hepatocellular carcinomas by cDNA microarray. World J Gastroenterol 2005; 11(4): 463-468 [PMID: 15641127 DOI: 10.3748/wjg.v11.i4.463] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
62 Hua Z, Chen J, Sun B, Zhao G, Zhang Y, Fong Y, Jia Z, Yao L. Specific expression of osteopontin and S100A6 in hepatocellular carcinoma. Surgery. 2011;149:783-791. [PMID: 21310450 DOI: 10.1016/j.surg.2010.12.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
63 Ma R, Feng Y, Lin S, Chen J, Lin H, Liang X, Zheng H, Cai X. Mechanisms involved in breast cancer liver metastasis. J Transl Med 2015;13:64. [PMID: 25885919 DOI: 10.1186/s12967-015-0425-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
64 Tokairin T, Nishikawa Y, Watanabe H, Doi Y, Omori Y, Yoshioka T, Yamamoto Y, Yoshida M, Nishimura T, Li Q. Osteopontin expression in the liver with severe perisinusoidal fibrosis: autopsy case of Down syndrome with transient myeloproliferative disorder. Pathol Int. 2008;58:64-68. [PMID: 18067644 DOI: 10.1111/j.1440-1827.2007.02191.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
65 Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe'er J. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Ophthalmol Vis Sci 2006;47:802-6. [PMID: 16505010 DOI: 10.1167/iovs.05-0422] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
66 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
67 Sun SJ, Wu CC, Sheu GT, Chang HY, Chen MY, Lin YY, Chuang CY, Hsu SL, Chang JT. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth. Oncotarget 2016;7:55572-84. [PMID: 27487131 DOI: 10.18632/oncotarget.10865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
68 Bruha R, Jachymova M, Petrtyl J, Dvorak K, Lenicek M, Urbanek P, Svestka T, Vitek L. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. World J Gastroenterol 2016; 22(12): 3441-3450 [PMID: 27022226 DOI: 10.3748/wjg.v22.i12.3441] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
69 Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol. 2004;68:2367-2378. [PMID: 15548383 DOI: 10.1016/j.bcp.2004.08.022] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
70 Kim J, Ki SS, Lee SD, Han CJ, Kim YC, Park SH, Cho SY, Hong YJ, Park HY, Lee M. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. Am J Gastroenterol. 2006;101:2051-2059. [PMID: 16848813 DOI: 10.1111/j.1572-0241.2006.00679.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 5.6] [Reference Citation Analysis]
71 Huang F, Cai P, Wang Y, Zhou X, Chen H, Liao W, Mao Y, Zha X, Zhang H, Hu Z. Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development. Oncotarget 2017;8:65789-99. [PMID: 29029472 DOI: 10.18632/oncotarget.19477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Guo H, Marroquin CE, Wai PY, Kuo PC. Nitric Oxide-Dependent Osteopontin Expression Induces Metastatic Behavior in HepG2 Cells. Dig Dis Sci 2005;50:1288-98. [DOI: 10.1007/s10620-005-2775-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
73 Wai PY, Kuo PC. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 2008;27:103-18. [PMID: 18049863 DOI: 10.1007/s10555-007-9104-9] [Cited by in Crossref: 230] [Cited by in F6Publishing: 222] [Article Influence: 16.4] [Reference Citation Analysis]
74 Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis. 2011;32:477-487. [PMID: 21252118 DOI: 10.1093/carcin/bgr009] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 10.0] [Reference Citation Analysis]
75 Batorfi J, Fulop V, Kim J, Genest DR, Doszpod J, Mok SC, Berkowitz RS. Osteopontin is down-regulated in hydatidiform mole. Gynecologic Oncology 2003;89:134-9. [DOI: 10.1016/s0090-8258(03)00067-2] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
76 Stivarou T, Patsavoudi E. Extracellular molecules involved in cancer cell invasion. Cancers (Basel). 2015;7:238-265. [PMID: 25629807 DOI: 10.3390/cancers7010238] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
77 Jang T, Savarese T, Low HP, Kim S, Vogel H, Lapointe D, Duong T, Litofsky NS, Weimann JM, Ross AH, Recht L. Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am J Pathol 2006;168:1676-85. [PMID: 16651633 DOI: 10.2353/ajpath.2006.050400] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
78 Mi Z, Guo H, Wai PY, Gao C, Wei J, Kuo PC. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior. J Biol Chem 2004;279:46659-67. [PMID: 15347645 DOI: 10.1074/jbc.M407952200] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
79 Kaleta B. Osteopontin and Transplantation: Where Are We Now? Arch Immunol Ther Exp (Warsz) 2021;69:15. [PMID: 34019147 DOI: 10.1007/s00005-021-00617-6] [Reference Citation Analysis]
80 Hu H, Liu Z, Liu C. Correlation of OPN gene expression with proliferation and apoptosis of ovarian cancer cells and prognosis of patients. Oncol Lett 2019;17:2788-94. [PMID: 30854053 DOI: 10.3892/ol.2019.9896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
81 Gao C, Mi Z, Guo H, Wei J, Wai PY, Kuo PC. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line. Biochemical and Biophysical Research Communications 2004;321:1010-6. [DOI: 10.1016/j.bbrc.2004.07.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
82 Denhardt DT, Mistretta D, Chambers AF, Krishna S, Porter JF, Raghuram S, Rittling SR. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clin Exp Metastasis 2003;20:77-84. [PMID: 12650610 DOI: 10.1023/a:1022550721404] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
83 Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1035-G1043. [PMID: 15256362 DOI: 10.1152/ajpgi.00199.2004] [Cited by in Crossref: 198] [Cited by in F6Publishing: 198] [Article Influence: 11.0] [Reference Citation Analysis]
84 Castello LM, Raineri D, Salmi L, Clemente N, Vaschetto R, Quaglia M, Garzaro M, Gentilli S, Navalesi P, Cantaluppi V, Dianzani U, Aspesi A, Chiocchetti A. Osteopontin at the Crossroads of Inflammation and Tumor Progression. Mediators Inflamm 2017;2017:4049098. [PMID: 28769537 DOI: 10.1155/2017/4049098] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 14.2] [Reference Citation Analysis]
85 Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS, Ou YH, Hsu HC. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur J Cancer. 2007;43:736-744. [PMID: 17267202 DOI: 10.1016/j.ejca.2006.11.020] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
86 Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res. 2004;121:228-241. [PMID: 15501463 DOI: 10.1016/j.jss.2004.03.028] [Cited by in Crossref: 252] [Cited by in F6Publishing: 227] [Article Influence: 14.0] [Reference Citation Analysis]
87 Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother 2021;146:112530. [PMID: 34915416 DOI: 10.1016/j.biopha.2021.112530] [Reference Citation Analysis]
88 Qin LX, Tang ZY. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol. 2004;130:497-513. [PMID: 15205947 DOI: 10.1007/s00432-004-0572-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 129] [Article Influence: 5.8] [Reference Citation Analysis]
89 Sulpice L, Rayar M, Desille M, Turlin B, Fautrel A, Boucher E, Llamas-Gutierrez F, Meunier B, Boudjema K, Clément B. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. Hepatology. 2013;58:1992-2000. [PMID: 23775819 DOI: 10.1002/hep.26577] [Cited by in Crossref: 77] [Cited by in F6Publishing: 125] [Article Influence: 8.6] [Reference Citation Analysis]
90 Hamaoka K, Nagoshi S, Sugawara K, Naiki K, Uchida Y, Inao M, Nakayama N, Fujiwara K, Mochida S. SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV. Hepatol Int 2013;7:683-92. [PMID: 26201802 DOI: 10.1007/s12072-012-9404-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
91 Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Cui X, Ajioka Y, Hatakeyama K. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma. Hum Pathol. 2008;39:1777-1783. [PMID: 18701136 DOI: 10.1016/j.humpath.2008.05.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
92 Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res. 2005;57:837-844. [PMID: 15845635 DOI: 10.1203/01.pdr.0000161414.99181.61] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
93 Mukama O, Wu W, Wu J, Lu X, Liu Y, Liu Y, Liu J, Zeng L. A highly sensitive and specific lateral flow aptasensor for the detection of human osteopontin. Talanta 2020;210:120624. [PMID: 31987218 DOI: 10.1016/j.talanta.2019.120624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
94 Xie H, Song J, Du R, Liu K, Wang J, Tang H, Bai F, Liang J, Lin T, Liu J. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma. Dig Liver Dis. 2007;39:167-172. [PMID: 17161983 DOI: 10.1016/j.dld.2006.10.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
95 Huang H, Zhang XF, Zhou HJ, Xue YH, Dong QZ, Ye QH, Qin LX. Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection. Cancer Sci. 2010;101:1314-1319. [PMID: 20345480 DOI: 10.1111/j.1349-7006.2010.01524.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
96 Guzman G, Cotler SJ, Lin AY, Maniotis AJ, Folberg R. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med 2007;131:1776-81. [PMID: 18081435 DOI: 10.5858/2007-131-1776-APSOVM] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 0.6] [Reference Citation Analysis]
97 Shi M, Wang S, Zheng S, Hou P, Dong L, He M, Wu C, Zhang X, Zuo F, Xu K, Li J. Activatable MRI-monitoring gene delivery for the theranostic of renal carcinoma. Colloids and Surfaces B: Biointerfaces 2020;185:110625. [DOI: 10.1016/j.colsurfb.2019.110625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Wang WJ, Wang H, Hua TY, Song W, Zhu J, Wang JJ, Huang YQ, Ding ZL. Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma. Front Genet 2020;11:55. [PMID: 32158466 DOI: 10.3389/fgene.2020.00055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
99 Beckebaum S, Chen X, Sotiropoulos GC, Radtke A, Daoudaki M, Baba HA, Wohlschlaeger J, Broelsch CE, Gerken G, Cicinnati VR. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection. Transplant Proc. 2008;40:3182-3184. [PMID: 19010227 DOI: 10.1016/j.transproceed.2008.08.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
100 Terashi T, Aishima S, Taguchi K, Asayama Y, Sugimachi K, Matsuura S, Shimada M, Maehara S, Maehara Y, Tsuneyoshi M. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma. Liver Int. 2004;24:38-45. [PMID: 15101999 DOI: 10.1111/j.1478-3231.2004.00886.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
101 Wai PY, Mi Z, Gao C, Guo H, Marroquin C, Kuo PC. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem. 2006;281:18973-18982. [PMID: 16670084 DOI: 10.1074/jbc.m511962200] [Cited by in Crossref: 58] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
102 Wangensteen KJ, Wilber A, Keng VW, He Z, Matise I, Wangensteen L, Carson CM, Chen Y, Steer CJ, McIvor RS. A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver. Hepatology. 2008;47:1714-1724. [PMID: 18435462 DOI: 10.1002/hep.22195] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
103 Nagoshi S. Osteopontin: Versatile modulator of liver diseases. Hepatol Res. 2014;44:22-30. [PMID: 23701387 DOI: 10.1111/hepr.12166] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
104 El-Khazragy N, Khalifa MM, Salem AM, Swellam M, Hegazy M. Evaluation of Osteopontin and Pokémon genes expression in hepatitis C virus-associated hepatocellular carcinoma. J Cell Biochem 2018. [PMID: 30417409 DOI: 10.1002/jcb.28018] [Reference Citation Analysis]
105 Kim SH, Chung YH, Yang SH, Kim JA, Jang MK, Kim SE, Lee D, Lee SH, Lee D, Kim KM. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization. Korean J Hepatol. 2009;15:320-330. [PMID: 19783881 DOI: 10.3350/kjhep.2009.15.3.320] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
106 Bhattacharya SD, Garrison J, Guo H, Mi Z, Markovic J, Kim VM, Kuo PC. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines. Surgery. 2010;148:291-297. [PMID: 20576283 DOI: 10.1016/j.surg.2010.05.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
107 Malarkey DE, Parker JS, Turman CA, Scott AM, Paules RS, Collins J, Maronpot RR. Microarray data analysis of mouse neoplasia. Toxicol Pathol 2005;33:127-35. [PMID: 15805064 DOI: 10.1080/01926230590888315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]